Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T15:55:16.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page. The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T15:30:04.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1 while the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T15:57:09.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the previous content with an error screen. This prevents viewing trial details on this record.
    Difference
    19%
    Check dated 2026-09-22T21:58:58.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now shown on the page, replacing the previous Revision: v3.6.6. This represents a page version update resulting from maintenance or UI changes, with no changes to the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-09-15T22:04:59.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6. This indicates a small maintenance update to the site's versioning rather than a change to content or user-visible features.
    Difference
    0.1%
    Check dated 2026-09-01T18:20:37.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.